Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Overview
  • Distribution by PR Newswire
  • AI Tools
  • Multichannel Amplification
  • Guaranteed Paid Placement
  • SocialBoost
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Overview
  • Distribution by PR Newswire
  • AI Tools
  • Multichannel Amplification
  • SocialBoost
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

JSS Medical Research, em Montreal, Quebec, Canadá conclui aquisição da LatAm Clinical Trials na América do Sul e Central


News provided by

JSS Medical Research Inc.

Sep 27, 2013, 08:51 ET

Share this article

Share toX

Share this article

Share toX

MONTREAL, 27 setembro de 2013 /PRNewswire/ -- A JSS Medical Research, uma organização de pesquisa de contrato (CRO) de serviço completo, anunciou hoje que adquiriu a LatAm Clinical Trials, uma CRO multinacional na América do Sul e Central.

A LatAm Clinical Trials foi fundada por um grupo de empresários, em 2005 e tem apoiado a indústria farmacêutica com pesquisa clínica para Fase I - IV e estudos de pós-comercialização, com escritórios nos EUA, Colômbia e Panamá. A equipe de pesquisa clínica está localizada nos países andinos da América do Sul e na América Central, dando acesso à expertise e infraestrutura médicas substanciais subutilizadas em toda a região que inclui Colômbia, Panamá, Costa Rica, Guatemala, República Dominicana, Peru, Venezuela e Equador. O alcance geográfico da LatAm Clinical Trials estende-se a outros países da América Latina através de parcerias com outras CROs locais no México, Argentina, Brasil e Chile. A empresa conquistou a reputação de oferecer serviços de pesquisa clínica de alto padrão, inclusive estudos iniciais, suporte regulatório, gestão de projetos, gestão local, monitoramento, controle de qualidade e treinamento.

A LatAm traz qualidade e valor para os programas de desenvolvimento clínico dos clientes, oferecendo flexibilidade de serviços, juntamente com um extenso conhecimento de testes clínicos e requisitos regulamentares da indústria latino-americana, juntamente com uma extensa rede de pesquisadores clínicos experientes. Com oito anos de experiência, a LatAm Clinical Trials é reconhecida como uma das principais CROs regionais com relações estabelecidas a longo prazo nas indústrias de produtos farmacêuticos, dispositivos médicos e biotecnologia.

"É um dia emocionante e importante para a JSS Medical Research", disse o Dr. John Sampalis, CEO e fundador da JSS Medical Research. "Estamos constantemente melhorando as nossas ofertas de serviços tanto em termos de alcance geográfico quanto em gama de serviços, respondendo às demandas do setor e necessidades específicas de nossos clientes. A adição da LatAm Clinical Trials à JSS Medical Research solidifica nossa presença na América Latina, permitindo a expansão dos nossos serviços na região e melhorando a nossa posição atual, adicionando serviços clínicos regionais, além dos serviços já estabelecidos científicos, bioestáticos, de gestão de dados, pesquisa de resultados, economia da saúde e publicações médicas."

"A aquisição da LatAm Clinical Trials é um marco importante para a JSS Medical Research em seu caminho para se tornar uma CRO líder de nicho internacional que oferece aos nossos clientes os serviços científicos e operacionais melhores possíveis e incondicionais. A JSS Medical Research é uma empresa que foi criada sobre uma base científica e desenvolve suas operações clínicas sobre este fundamento. A filosofia da LatAm Clinical Trial com ênfase em operações clínicas de alta qualidade regidas pelo alto rigor científico e a equipe de gestão composta por médicos, epidemiologistas e pesquisadores clínicos é inteiramente compatível com a visão da JSS Medical Research. As sinergias nos permitirão continuar a oferecer serviços de testes clínicos para estudos de Fase I - IV, mas também nos permitirão ajudar a nossa indústria e parceiros do governo na concepção e execução dos tão necessários programas epidemiológicos clínicos de pós-aprovação."

"O ritmo de crescimento da JSS Medical Research leva-nos à união com uma empresa, em um momento muito empolgante e o fato de fazer parte deste grupo nos permitirá o melhor aproveitamento da nossa experiência, oferecendo o acesso de nossos clientes locais a localidades e pessoal internacionais com o mais alto nível possível de expertise e conhecimento científicos, juntamente com experiência mundial em operações de testes clínicos", disse Dr. Diana Valencia, cofundadora e CEO da LatAm Clinical Trials. "A ética de negócios de ambas as empresas é focada em um compromisso com a excelência e qualidade, e isso só pode ser reforçado pela combinação das duas organizações."

Sobre a JSS Medical Research

A JSS Medical Research é uma CRO de serviço completo com o seu escritório corporativo no Canadá e um escritório regional na Colômbia. A empresa oferece serviços de gestão de testes clínicos em Fase I - IV em uma ampla gama de áreas terapêuticas e é líder em Estudos Epidemiológicos Clínicos de Pós-aprovação (PACES), inclusive Estudos Observacionais de Pós-comercialização, Pesquisa de Resultados de Saúde e Economia de Saúde. Os serviços personalizados com atenção direta ao cliente de equipes seniores experientes científicas e clínicas posicionam a JSS Medical Research como uma CRO única no mundo. Para mais informações, por favor, visite nosso website em www.jssresearch.com.

Para mais informações:

JSS Medical Research Inc.

Dr. Sanjay Machado
Diretor executivo, Operações Comerciais Globais
JSS Medical Research Inc.
Tel.: +1-514-934-6116, ramal 224
E-mail: [email protected]

Toni Rinow, Ph.D., MBA
Diretor financeiro
JSS Medical Research Inc.
Tel.: +1-514-934-6116, ramal 401
E-mail: [email protected]

FONTE  JSS Medical Research Inc.

FONTE JSS Medical Research Inc.

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.